JW Lifescience Corporation (KRX:234080)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,060
-210 (-1.58%)
At close: Mar 3, 2026
23.32%
Market Cap 205.48B
Revenue (ttm) 248.30B
Net Income (ttm) 47.59B
Shares Out 15.48M
EPS (ttm) 3,073.31
PE Ratio 4.32
Forward PE n/a
Dividend 500.00 (3.77%)
Ex-Dividend Date Mar 31, 2026
Volume 84,233
Average Volume 68,697
Open 13,140
Previous Close 13,270
Day's Range 13,060 - 13,440
52-Week Range 10,350 - 15,580
Beta 0.33
RSI 46.63
Earnings Date Feb 5, 2026

About JW Lifescience

JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea. [Read more]

Sector Healthcare
Founded 1994
Employees 297
Stock Exchange Korea Stock Exchange
Ticker Symbol 234080
Full Company Profile

Financial Performance

In 2024, JW Lifescience's revenue was 222.48 billion, an increase of 7.55% compared to the previous year's 206.86 billion. Earnings were 43.99 billion, an increase of 56.29%.

Financial Statements

News

There is no news available yet.